Company Search:
Advanced Search
Sponsored Links
Morphosys AG - ADR Company Snapshot
Morphosys AG - ADR operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Morphosys AG - ADR with three other companies in this sector in the United States: Foundation Medicine Inc (2015 sales of $93.20 million of which 100% was Diagnostic), National Research Corporation ($102.34 million of which 100% was Performance Tracking), and Retrophin Inc ($99.89 million of which 100% was Biotechnology).

Sales Analysis. During the year ended December of 2015, sales at Morphosys AG - ADR were $117.16 million. This is an increase of 38.7% versus 2014, when the company's sales were $84.48 million. The sales level in 2015 was fairly close to the level five years ago: in 2010, Morphosys AG - ADR had sales of $114.89 million. Sales of Proprietary Development saw an increase that was more than double the company's growth rate: sales were up 232.9% in 2015, from $19.86 million to $66.11 million. Not all segments of Morphosys AG - ADR experienced an increase in sales in 2015: sales of Partnered Discovery fell 21.0% to $51.05 million.
  Stock Performance Chart for Morphosys AG - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/25/2016): 23.23
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Morphosys AG - ADR Key Data:
  Ticker: MPSY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 117,158,544
(Year Ending Jan 2016).
Employees: 365
  Currency: U.S. Dollars Market Cap: 1,214,435,595
  Fiscal Yr Ends: December Shares Outstanding: 52,278,760
  Share Type: Stammaktie Closely Held Shares: 1,587,898
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.